294 related articles for article (PubMed ID: 26847337)
21. Metastatic renal cell carcinoma (RCC): spontaneous regression, long-term survival and late recurrence.
de Riese W; Goldenberg K; Allhoff E; Stief C; Schlick R; Liedke S; Jonas U
Int Urol Nephrol; 1991; 23(1):13-25. PubMed ID: 1938215
[TBL] [Abstract][Full Text] [Related]
22. Contralateral metachronous tumor occurrence is more frequently associated with distant metastases or postoperative intrarenal recurrence in renal cell carcinoma patients.
Amano H; Kondo T; Hashimoto Y; Kobayashi H; Iizuka J; Shimada K; Nakazawa H; Ito F; Tanabe K
Int J Urol; 2010 Jul; 17(7):615-22. PubMed ID: 20482658
[TBL] [Abstract][Full Text] [Related]
23. Predictors of oncological outcome after resection of locally recurrent renal cell carcinoma.
Margulis V; McDonald M; Tamboli P; Swanson DA; Wood CG
J Urol; 2009 May; 181(5):2044-51. PubMed ID: 19286220
[TBL] [Abstract][Full Text] [Related]
24. Oncological outcome of minimum incision endoscopic radical nephrectomy for pathologically organ confined renal cell carcinoma.
Iimura Y; Kihara K; Saito K; Masuda H; Kobayashi T; Kawakami S
Int J Urol; 2008 Jan; 15(1):44-7. PubMed ID: 18184170
[TBL] [Abstract][Full Text] [Related]
25. Spinal metastasectomy of renal cell carcinoma: A 16-year single center experience with a minimum 3-year follow-up.
Kato S; Murakami H; Demura S; Nambu K; Fujimaki Y; Yoshioka K; Kawahara N; Tomita K; Tsuchiya H
J Surg Oncol; 2016 Apr; 113(5):587-92. PubMed ID: 26846902
[TBL] [Abstract][Full Text] [Related]
26. Outcomes and clinicopathologic variables associated with late recurrence after nephrectomy for localized renal cell carcinoma.
Kim SP; Weight CJ; Leibovich BC; Thompson RH; Costello BA; Cheville JC; Lohse CM; Boorjian SA
Urology; 2011 Nov; 78(5):1101-6. PubMed ID: 21903243
[TBL] [Abstract][Full Text] [Related]
27. Cancer Characteristics and Current Treatments of Patients with Renal Cell Carcinoma in Sweden.
Thorstenson A; Harmenberg U; Lindblad P; Holmström B; Lundstam S; Ljungberg B
Biomed Res Int; 2015; 2015():456040. PubMed ID: 26539495
[TBL] [Abstract][Full Text] [Related]
28. Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors.
Santoni M; Conti A; Partelli S; Porta C; Sternberg CN; Procopio G; Bracarda S; Basso U; De Giorgi U; Derosa L; Rizzo M; Ortega C; Massari F; Iacovelli R; Milella M; Di Lorenzo G; Buti S; Cerbone L; Burattini L; Montironi R; Santini D; Falconi M; Cascinu S
Ann Surg Oncol; 2015; 22(6):2094-100. PubMed ID: 25472645
[TBL] [Abstract][Full Text] [Related]
29. Diagnostic radiation exposure during surveillance in patients with pT1a renal cell carcinoma.
Lipsky MJ; Shapiro EY; Hruby GW; McKiernan JM
Urology; 2013 Jun; 81(6):1190-5. PubMed ID: 23540857
[TBL] [Abstract][Full Text] [Related]
30. [Local recurrence of the renal cell carcinoma in renal fossa after complete radical nephrectomy. What are the risk factors?].
Ormanov D; Kirilov S; Ianev K; Georgiev M; Simeonov P; Dimitrov P; Bonev K; Vasilev V; Mavrov Kh; Panchev P
Khirurgiia (Sofiia); 2008; (1-2):34-6. PubMed ID: 18983006
[TBL] [Abstract][Full Text] [Related]
31. Outcome of surgical treatment of isolated local recurrence after radical nephrectomy for renal cell carcinoma.
Schrodter S; Hakenberg OW; Manseck A; Leike S; Wirth MP
J Urol; 2002 Apr; 167(4):1630-3. PubMed ID: 11912377
[TBL] [Abstract][Full Text] [Related]
32. Therapy of local recurrence of renal cell carcinoma.
Wiesner C; Jakse G; Rohde D
Oncol Rep; 2002; 9(1):189-92. PubMed ID: 11748481
[TBL] [Abstract][Full Text] [Related]
33. Patterns of Presentation and Treatment Outcomes of Non-clear-cell Renal Cell Carcinoma and Sarcomatoid Renal Cell Carcinoma Patients in 2 Tertiary Referral Centers in Sydney, Australia.
Naher S; Padinharakam S; Balakrishnar B; Chua W; Descallar J; Adams D; de Souza P; Harrison M; Lim S
Clin Genitourin Cancer; 2019 Jun; 17(3):e565-e569. PubMed ID: 30935815
[TBL] [Abstract][Full Text] [Related]
34. Clinicopathological characteristics and oncological outcomes in patients with renal cell carcinoma registered in 2007: The first large-scale multicenter study from the Cancer Registration Committee of the Japanese Urological Association.
Kanayama HO; Fukumori T; Fujimoto H; Nakanishi H; Ohyama C; Suzuki K; Nishiyama H; Eto M; Miki T; Kamoi K; Kubota Y; Takahashi S; Homma Y; Naito S
Int J Urol; 2015 Sep; 22(9):S1-7. PubMed ID: 26332059
[TBL] [Abstract][Full Text] [Related]
35. Targeted therapy after complete resection of metastatic lesions in metastatic renal cell carcinoma.
Park YH; Jung JW; Lee BK; Lee S; Jeong SJ; Byun SS; Lee SE
Int J Urol; 2015 Feb; 22(2):153-7. PubMed ID: 25421791
[TBL] [Abstract][Full Text] [Related]
36. Patterns of relapse and response to retreatment in patients with metastatic melanoma or renal cell carcinoma who responded to interleukin-2-based immunotherapy.
Lee DS; White DE; Hurst R; Rosenberg SA; Yang JC
Cancer J Sci Am; 1998; 4(2):86-93. PubMed ID: 9532410
[TBL] [Abstract][Full Text] [Related]
37. Renal cell carcinoma with nodal metastases in the absence of distant metastatic disease (clinical stage TxN1-2M0): the impact of aggressive surgical resection on patient outcome.
Canfield SE; Kamat AM; Sánchez-Ortiz RF; Detry M; Swanson DA; Wood CG
J Urol; 2006 Mar; 175(3 Pt 1):864-9. PubMed ID: 16469567
[TBL] [Abstract][Full Text] [Related]
38. Systematic Review of the Management of Local Kidney Cancer Relapse.
Kriegmair MC; Bertolo R; Karakiewicz PI; Leibovich BC; Ljungberg B; Mir MC; Ouzaid I; Salagierski M; Staehler M; van Poppel H; Wood CC; Capitanio U;
Eur Urol Oncol; 2018 Dec; 1(6):512-523. PubMed ID: 31158097
[TBL] [Abstract][Full Text] [Related]
39. Regional thermoablation of local or metastatic renal cell carcinoma.
Rohde D; Albers C; Mahnken A; Tacke J
Oncol Rep; 2003; 10(3):753-7. PubMed ID: 12684654
[TBL] [Abstract][Full Text] [Related]
40. Metastatic renal cell carcinoma with concurrent inferior vena caval invasion: long-term survival after combination therapy with radical nephrectomy, vena caval thrombectomy and postoperative immunotherapy.
Naitoh J; Kaplan A; Dorey F; Figlin R; Belldegrun A
J Urol; 1999 Jul; 162(1):46-50. PubMed ID: 10379737
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
